Moderna, Inc. stock price
Today's NASDAQ:MRNA chart, history & news
Price:
157.40
USD
Change:
+2.59 (1.67%)
Key stats
| Price open | 153.84 |
|---|---|
| Previous close | 154.81 |
| Market cap | 62.92B |
| Volume | 15.35M |
| Day high | 157.78 |
| Day low | 145.25 |
| Year high | 189.26 |
| Year low | 19.31 |
| Year to date change | 52.34% |
| P/E ratio | -96.56 |
Company Profile
Fundamentals
Insider Information
News
Company information
Company name
Moderna, Inc.
Exchange
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Stephane Bancel
Address
200 Technology Sq, Cambridge, Massachusetts, 02139-3578
Country
United States
Contact information
16177146500
Website
https://www.modernatx.com/
Latest Moderna, Inc. news
18th February
What to make of Pfizer, Moderna insiders dumping stock?
Moderna, Inc. earnings reports (2020)
| Q3 2020 | Q2 2020 | Q1 2020 | Q1 2020 | |
|---|---|---|---|---|
| Actual EPS | -0.59 | -0.31 | -0.35 | -0.35 |
| Consensus EPS | -0.38 | -0.35 | -0.35 | -0.35 |
| Announce Time | BTO | BTO | BTO | BTO |
| Number of Estimates | 11 | 11 | 9 | 9 |
| EPS Surprise Dollar | -0.21 | 0.04 | 0 | 0 |
| EPS Report Date | 29-10-2020 | 05-08-2020 | 06-05-2020 | 06-05-2020 |
| Fiscal End Date | 30-09-2020 | 30-06-2020 | 30-03-2020 | 30-03-2020 |
| Year Ago | -0.37 | -0.41 | -0.4 | -0.4 |
| Year Ago % Change | -59.46% | 24.39% | 12.5% | 12.5% |
Moderna, Inc. earnings reports (2019)
| Q4 2019 | Q3 2019 | Q2 2019 | |
|---|---|---|---|
| Actual EPS | -0.37 | -0.37 | -0.41 |
| Consensus EPS | -0.42 | -0.44 | -0.45 |
| Announce Time | BTO | BTO | BTO |
| Number of Estimates | 8 | 7 | 6 |
| EPS Surprise Dollar | 0.05 | 0.07 | 0.04 |
| EPS Report Date | 26-02-2020 | 06-11-2019 | 06-08-2019 |
| Fiscal End Date | 31-12-2019 | 29-09-2019 | 29-06-2019 |
| Year Ago | -0.44 | -0.3 | N.A |
| Year Ago % Change | 15.91% | -23.33% | N.A |
Moderna, Inc. income statements (2020) (USD)
| October 2020 | September 2020 | June 2020 | March 2020 | March 2020 | |
|---|---|---|---|---|---|
| Total Revenue | 157.91M | N.A | N.A | N.A | N.A |
| Cost of Revenue | 0 | N.A | N.A | N.A | N.A |
| Gross Profit | 157.91M | N.A | N.A | N.A | N.A |
| Research & Development | 344.49M | 344.49M | 144.26M | 107.69M | 107.69M |
| Selling General & Admin | 48.54M | 48.54M | 36.62M | 24.11M | 24.11M |
| Operating Expense | 393.03M | N.A | N.A | N.A | N.A |
| Operating Income | -235.12M | -235.12M | -122.13M | -130.86M | -130.86M |
| Other Income Expense Net | 0 | 2.35M | 5.56M | 6.70M | 6.70M |
| EBIT | -235.12M | -235.12M | -122.13M | -130.86M | -130.86M |
| Interest Income | -5.57M | N.A | 1.88M | 1.67M | 1.67M |
| Pretax Income | -232.77M | -232.77M | -116.57M | -124.16M | -124.16M |
| Income Tax | 864K | 864K | 148K | 66K | 66K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Net Income | -233.64M | -233.64M | -116.71M | -124.23M | -124.23M |
| Net Income Basic | -233.64M | -233.64M | -116.71M | -124.23M | -124.23M |
Moderna, Inc. income statements (2019) (USD)
| December 2019 | September 2019 | June 2019 | March 2019 | |
|---|---|---|---|---|
| Total Revenue | N.A | N.A | N.A | N.A |
| Cost of Revenue | N.A | N.A | N.A | N.A |
| Gross Profit | N.A | N.A | N.A | N.A |
| Research & Development | 109.82M | 112.42M | 128.50M | 130.58M |
| Selling General & Admin | 25.86M | 28.19M | 21.02M | 19.96M |
| Operating Expense | N.A | N.A | N.A | N.A |
| Operating Income | -130.56M | -130.86M | -143.94M | -141.83M |
| Other Income Expense Net | 6.15M | 7.49M | 8.56M | 9.15M |
| EBIT | -130.56M | -130.86M | -143.94M | -141.83M |
| Interest Income | 2M | 1.54M | 1.54M | 1.53M |
| Pretax Income | -124.41M | -123.37M | -135.38M | -132.68M |
| Income Tax | -169K | -178K | -324K | -24K |
| Minority Interest | 0 | 0 | 0 | 0 |
| Net Income | -124.24M | -123.19M | -135.05M | -132.66M |
| Net Income Basic | -124.24M | -123.19M | -135.05M | -132.66M |
Moderna, Inc. income statements (2018) (USD)
| December 2018 | September 2018 | |
|---|---|---|
| Total Revenue | N.A | N.A |
| Cost of Revenue | N.A | N.A |
| Gross Profit | N.A | N.A |
| Research & Development | 150.43M | 109.05M |
| Selling General & Admin | 30.67M | 12.04M |
| Operating Expense | N.A | N.A |
| Operating Income | -153.03M | -85.82M |
| Other Income Expense Net | 11.77M | 5.49M |
| EBIT | -153.03M | -85.82M |
| Interest Income | 1.53M | N.A |
| Pretax Income | -141.26M | -80.33M |
| Income Tax | 168K | N.A |
| Minority Interest | 0 | 0 |
| Net Income | -141.43M | -80.33M |
| Net Income Basic | -144.1M | -87.82M |
Moderna, Inc. income statements (2017) (USD)
| December 2017 | September 2017 | |
|---|---|---|
| Total Revenue | N.A | N.A |
| Cost of Revenue | N.A | N.A |
| Gross Profit | N.A | N.A |
| Research & Development | 117.83M | 93.61M |
| Selling General & Admin | 9.99M | 11.60M |
| Operating Expense | N.A | N.A |
| Operating Income | -41.83M | -67.87M |
| Other Income Expense Net | 3.71M | 3.09M |
| EBIT | -41.83M | -67.87M |
| Interest Income | N.A | N.A |
| Pretax Income | -38.12M | -64.79M |
| Income Tax | -171K | -2K |
| Minority Interest | 0 | 0 |
| Net Income | -37.94M | -64.78M |
| Net Income Basic | -41.43M | -68.26M |
Moderna, Inc. balance sheet (2020) (USD)
| October 2020 | June 2020 | March 2020 | March 2020 | |
|---|---|---|---|---|
| Current Cash | 3.28B | 1.76B | 392.75M | 392.75M |
| Receivables | 213.45M | 33.36M | 7.30M | 7.30M |
| Inventory | 0 | N.A | N.A | N.A |
| Current Assets | 3.58B | 2.80B | 1.25B | 1.25B |
| Other Current Assets | 86.42M | 20.85M | 12.41M | 12.41M |
| Short Term Investments | 86.42M | 0.96B | 825.98M | 825.98M |
| Long Term Investments | 1.07B | 365.71M | 513.27M | 513.27M |
| Property/Plant Equipment | 276.91M | 321.99M | 302.60M | 302.60M |
| Good Will | N.A | N.A | N.A | N.A |
| Intangible Assets | 0 | N.A | N.A | N.A |
| Tangible Assets (Net) | 2.76B | 2.95B | 1.64B | 1.64B |
| Other Assets | 2.05M | 1.57M | 1.74M | 1.74M |
| Total Assets | 4.65B | 3.49B | 2.07B | 2.07B |
| Accounts Payable | 20.52M | 18.82M | 11.03M | 11.03M |
| Other Current Liabilities | 1.45B | 138.64M | 119.56M | 119.56M |
| Total Current Liabilities | 1.47B | 161.65M | 134.58M | 134.58M |
| Total Liabilities | 1.89B | 539.12M | 426.67M | 426.67M |
| Long Term Debt | 108.61M | 167.77M | 147.85M | 147.85M |
| Current Long Term Debt | 0 | N.A | N.A | N.A |
| Minority Interest | 0 | 0 | 0 | 0 |
| Common Stock | 4.73B | 393.28M | 370.10M | 370.10M |
| Treasury Stock | 0 | N.A | N.A | N.A |
| Retained Earnings | -1.97B | -1.74B | -1.62B | -1.62B |
| Capital Surplus | N.A | 4.68B | 3.27B | 3.27B |
| Shareholder Equity | 2.76B | 2.95B | 1.64B | 1.64B |
| Other Liabilities | N.A | N.A | N.A | N.A |
Moderna, Inc. balance sheet (2019) (USD)
| December 2019 | September 2019 | June 2019 | March 2019 | |
|---|---|---|---|---|
| Current Cash | 236.91M | 174.74M | 151.62M | 502.93M |
| Receivables | 5.37M | 8.22M | 4.52M | 6.61M |
| Inventory | N.A | N.A | N.A | N.A |
| Current Assets | 1.13B | 1.09B | 1.10B | 1.14B |
| Other Current Assets | 8.48M | 9.73M | 9.20M | 7.90M |
| Short Term Investments | 867.12M | 884.83M | 0.92B | 605.99M |
| Long Term Investments | 170.78M | 290.65M | 365.03M | 437.66M |
| Property/Plant Equipment | 287.91M | 203.69M | 208.51M | 213.46M |
| Good Will | N.A | N.A | N.A | N.A |
| Intangible Assets | N.A | N.A | N.A | N.A |
| Tangible Assets (Net) | 1.17B | 1.25B | 1.34B | 1.45B |
| Other Assets | 1.93M | 2.09M | 14.32M | 14.26M |
| Total Assets | 1.59B | 1.59B | 1.69B | 1.81B |
| Accounts Payable | 7.09M | 11.74M | 29.61M | 38.51M |
| Other Current Liabilities | 132.44M | 136.11M | 132.38M | 112.89M |
| Total Current Liabilities | 143.12M | 147.84M | 161.99M | 159.16M |
| Total Liabilities | 414.61M | 339.09M | 346.73M | 360.17M |
| Long Term Debt | 132.36M | 33.80M | 33.59M | 33.38M |
| Current Long Term Debt | N.A | N.A | N.A | 7.76M |
| Minority Interest | 0 | 0 | 0 | 0 |
| Common Stock | 336.54M | 332.49M | 329.96M | 328.85M |
| Treasury Stock | N.A | N.A | N.A | N.A |
| Retained Earnings | -1.5B | -1.37B | -1.25B | -1.11B |
| Capital Surplus | 2.67B | 2.62B | 2.58B | 2.56B |
| Shareholder Equity | 1.17B | 1.25B | 1.34B | 1.45B |
| Other Liabilities | N.A | N.A | N.A | N.A |
Moderna, Inc. balance sheet (2018) (USD)
| December 2018 | September 2018 | |
|---|---|---|
| Current Cash | 658.96M | 167.89M |
| Receivables | 12.59M | 11.56M |
| Inventory | N.A | N.A |
| Current Assets | 1.56B | 1.12B |
| Other Current Assets | 10.40M | 27.32M |
| Short Term Investments | 863.06M | 0.91B |
| Long Term Investments | 175.62M | 161.89M |
| Property/Plant Equipment | 211.98M | 206.46M |
| Good Will | N.A | N.A |
| Intangible Assets | N.A | N.A |
| Tangible Assets (Net) | 1.53B | 1.08B |
| Other Assets | 11.54M | 2.87M |
| Total Assets | 1.96B | 1.49B |
| Accounts Payable | 31.21M | 24.36M |
| Other Current Liabilities | 181.09M | 162.06M |
| Total Current Liabilities | 222.80M | 186.42M |
| Total Liabilities | 431.91M | 412.73M |
| Long Term Debt | 33.49M | 26.89M |
| Current Long Term Debt | 10.50M | N.A |
| Minority Interest | 0 | 0 |
| Common Stock | 328.80M | 332.89M |
| Treasury Stock | N.A | N.A |
| Retained Earnings | -1.01B | -865.2M |
| Capital Surplus | 2.54B | 108.98M |
| Shareholder Equity | 1.53B | 1.08B |
| Other Liabilities | N.A | N.A |
Moderna, Inc. balance sheet (2017) (USD)
| December 2017 | |
|---|---|
| Current Cash | 135.81M |
| Receivables | 13.42M |
| Inventory | N.A |
| Current Assets | 783.22M |
| Other Current Assets | 9.59M |
| Short Term Investments | 621.17M |
| Long Term Investments | 157.65M |
| Property/Plant Equipment | 139.03M |
| Good Will | N.A |
| Intangible Assets | N.A |
| Tangible Assets (Net) | 625.30M |
| Other Assets | 4.59M |
| Total Assets | 1.08B |
| Accounts Payable | 20.73M |
| Other Current Liabilities | 170.74M |
| Total Current Liabilities | 191.46M |
| Total Liabilities | 459.19M |
| Long Term Debt | 15.69M |
| Current Long Term Debt | N.A |
| Minority Interest | 0 |
| Common Stock | 332.89M |
| Treasury Stock | N.A |
| Retained Earnings | -621.89M |
| Capital Surplus | 71.67M |
| Shareholder Equity | 625.30M |
| Other Liabilities | N.A |
Moderna, Inc. cash flow (2020) (USD)
| October 2020 | June 2020 | March 2020 | |
|---|---|---|---|
| Net Income | -233.64M | -116.71M | -124.23M |
| Depreciation | 23.55M | 7.60M | 7.45M |
| Changes in Receivables | 155.60M | -26.06M | -1.93M |
| Changes in Inventories | 0 | N.A | N.A |
| Cash Change | 559.29M | 1.37B | 155.84M |
| Cash Flow | -762.68M | -22.64M | -121.44M |
| Capital Expenditures | -44.15M | -18.63M | -6.22M |
| Investments | N.A | 31.11M | -309.8M |
| Investing Activity (other) | N.A | N.A | N.A |
| Total Investing Cash Flows | -1.48B | 12.48M | -316.02M |
| Dividends Paid | N.A | N.A | N.A |
| Net Borrowings | -3.25B | -1.19M | 15.24M |
| Other Financing Cash Flows | N.A | -241K | 241K |
| Cash Flow Financing | 1.99B | 1.38B | 593.30M |
| Exchange Rate Effect | N.A | N.A | N.A |
Moderna, Inc. cash flow (2019) (USD)
| December 2019 | September 2019 | June 2019 | March 2019 | |
|---|---|---|---|---|
| Net Income | -124.24M | -123.19M | -135.05M | -132.66M |
| Depreciation | 8.94M | 7.27M | 7.49M | 7.33M |
| Changes in Receivables | 2.85M | -3.7M | 2.09M | 5.97M |
| Changes in Inventories | N.A | N.A | N.A | N.A |
| Cash Change | 62.17M | 22.09M | -351.31M | -155.73M |
| Cash Flow | -107.45M | -107.05M | -112.22M | -143.93M |
| Capital Expenditures | -6.66M | -6.71M | -10.59M | -7.6M |
| Investments | 137.01M | 120.08M | -236.32M | -4.16M |
| Investing Activity (other) | N.A | N.A | N.A | N.A |
| Total Investing Cash Flows | 130.35M | 113.37M | -246.9M | -11.76M |
| Dividends Paid | N.A | N.A | N.A | N.A |
| Net Borrowings | 8.66M | 3.89M | 204K | -105K |
| Other Financing Cash Flows | N.A | -3.68M | 3.68M | N.A |
| Cash Flow Financing | 39.27M | 15.77M | 7.81M | -48K |
| Exchange Rate Effect | N.A | N.A | N.A | N.A |
Moderna, Inc. cash flow (2018) (USD)
| December 2018 | September 2018 | |
|---|---|---|
| Net Income | -141.43M | -80.33M |
| Depreciation | 7.35M | N.A |
| Changes in Receivables | -1.03M | 1.86M |
| Changes in Inventories | N.A | N.A |
| Cash Change | 491.30M | N.A |
| Cash Flow | -91.02M | N.A |
| Capital Expenditures | -13.64M | N.A |
| Investments | 20.05M | N.A |
| Investing Activity (other) | N.A | N.A |
| Total Investing Cash Flows | 6.41M | N.A |
| Dividends Paid | N.A | N.A |
| Net Borrowings | 187K | N.A |
| Other Financing Cash Flows | 11.64M | N.A |
| Cash Flow Financing | 575.92M | N.A |
| Exchange Rate Effect | N.A | N.A |
Moderna, Inc. cash flow (2017) (USD)
| December 2017 | |
|---|---|
| Net Income | -37.94M |
| Depreciation | 5.92M |
| Changes in Receivables | N.A |
| Changes in Inventories | N.A |
| Cash Change | 11.41M |
| Cash Flow | -102.93M |
| Capital Expenditures | -11.96M |
| Investments | 124.76M |
| Investing Activity (other) | N.A |
| Total Investing Cash Flows | 112.80M |
| Dividends Paid | N.A |
| Net Borrowings | 1.44M |
| Other Financing Cash Flows | N.A |
| Cash Flow Financing | 1.54M |
| Exchange Rate Effect | N.A |
Moderna, Inc. dividends (USD)
Insider Roster
| Entity name | Report date | Shares held |
|---|---|---|
| Zaks Tal Zvi | 29-12-2020 | 190,798 |
| Bancel Stephane | 29-12-2020 | 243,028 |
| Hoge Stephen | 28-12-2020 | 677,431 |
| HENDERSON LORI M. | 23-10-2020 | 367,522 |
| LANGER ROBERT | 30-04-2020 | 18,270 |
| SAGAN PAUL | 30-04-2020 | 18,270 |
| Nader Francois | 30-04-2020 | 18,270 |
| Slaoui Moncef | 30-04-2020 | 18,270 |
| KANIA EDWIN M JR | 14-01-2020 | 23,847 |
| HUTT PETER BARTON | 22-11-2019 | 502,752 |
Insider Summary
| Full name | Reported title | Total bought | Total sold | Net transacted |
|---|---|---|---|---|
| Flagship Ventures Fund IV General Partner LLC | 0 | 58,340,031 | -58,340,031 |
Insider Transactions
| Full name | Reported title | Effective date | Amount of shares | Price per share | Total cost |
|---|---|---|---|---|---|
| Hoge Stephen | President | 03-11-2020 | -10,000 | 66.75 | 667,500.00 |
| Hoge Stephen | President | 02-11-2020 | -10,000 | 68.02 | 680,200.00 |
| Zaks Tal Zvi | Chief Medical Officer | 02-11-2020 | +10,000 | N.A | N.A |
| Bancel Stephane | Chief Executive Officer | 02-11-2020 | -8,893 | 68.02 | 604,902.00 |
| Bancel Stephane | Chief Executive Officer | 30-10-2020 | -1,100 | 70.69 | 77,759.00 |
| Zaks Tal Zvi | Chief Medical Officer | 26-10-2020 | +10,000 | N.A | N.A |
| Hoge Stephen | President | 26-10-2020 | -300 | 71.13 | 21,339.00 |
| Hoge Stephen | President | 23-10-2020 | +10,000 | N.A | N.A |
| Bancel Stephane | Chief Executive Officer | 22-10-2020 | -10,000 | 68.58 | 685,800.00 |
| Bancel Stephane | Chief Executive Officer | 21-10-2020 | -1,000 | N.A | N.A |
| HENDERSON LORI M. | General Counsel and Secretary | 21-10-2020 | +32,000 | N.A | N.A |
| Bancel Stephane | Chief Executive Officer | 20-10-2020 | -8,455 | 72.05 | 609,183.00 |
| Zaks Tal Zvi | Chief Medical Officer | 19-10-2020 | -5,695 | 71.24 | 405,712.00 |
| Bancel Stephane | Chief Executive Officer | 16-10-2020 | -3,600 | 76.11 | 273,996.00 |
| Bancel Stephane | Chief Executive Officer | 15-10-2020 | -10,000 | 75.48 | 754,800.00 |
| Bancel Stephane | Chief Executive Officer | 14-10-2020 | -1,000 | N.A | N.A |
| Hoge Stephen | President | 13-10-2020 | +10,000 | 0.99 | +9,900.00 |
| Zaks Tal Zvi | Chief Medical Officer | 12-10-2020 | +10,000 | N.A | N.A |
| Bancel Stephane | Chief Executive Officer | 12-10-2020 | -8,219 | 73.61 | 605,001.00 |
| Hoge Stephen | President | 12-10-2020 | -1,256 | 75.38 | 94,677.30 |
| Bancel Stephane | Chief Executive Officer | 09-10-2020 | -400 | 73.55 | 29,420.00 |
| Bancel Stephane | Chief Executive Officer | 08-10-2020 | -10,000 | 73.50 | 735,000.00 |
| Bancel Stephane | Chief Executive Officer | 07-10-2020 | -1,000 | N.A | N.A |
| Zaks Tal Zvi | Chief Medical Officer | 05-10-2020 | -7,390 | 69.54 | 513,901.00 |
| Hoge Stephen | President | 05-10-2020 | +10,000 | N.A | N.A |
| Hoge Stephen | President | 02-10-2020 | +10,000 | N.A | N.A |
| Bancel Stephane | Chief Executive Officer | 02-10-2020 | -1,200 | 72.22 | 86,664.00 |
| Bancel Stephane | Chief Executive Officer | 01-10-2020 | -10,000 | 69.57 | 695,700.00 |
| Bancel Stephane | Chief Executive Officer | 30-09-2020 | -1,000 | N.A | N.A |
| Zaks Tal Zvi | Chief Medical Officer | 28-09-2020 | -10,178 | 70.64 | 718,974.00 |
| Bancel Stephane | Chief Executive Officer | 25-09-2020 | -3,479 | 69.29 | 241,060.00 |
| Bancel Stephane | Chief Executive Officer | 24-09-2020 | -10,000 | 65.50 | 655,000.00 |
| Hoge Stephen | President | 24-09-2020 | -1,000 | 66.35 | 66,350.00 |
| Bancel Stephane | Chief Executive Officer | 23-09-2020 | -1,000 | N.A | N.A |
| Hoge Stephen | President | 23-09-2020 | -2,700 | 68.11 | 183,897.00 |
| Zaks Tal Zvi | Chief Medical Officer | 21-09-2020 | +10,000 | N.A | N.A |
| Bancel Stephane | Chief Executive Officer | 17-09-2020 | -10,000 | 68.46 | 684,600.00 |
| Bancel Stephane | Chief Executive Officer | 16-09-2020 | -1,000 | N.A | N.A |
| Zaks Tal Zvi | Chief Medical Officer | 14-09-2020 | +10,000 | 20.93 | +209,300.00 |
| Hoge Stephen | President | 14-09-2020 | +10,000 | N.A | N.A |
| Bancel Stephane | Chief Executive Officer | 11-09-2020 | -2,695 | 58.96 | 158,897.00 |
| Bancel Stephane | Chief Executive Officer | 10-09-2020 | -7,030 | 56.96 | 400,429.00 |
| Bancel Stephane | Chief Executive Officer | 09-09-2020 | -1,000 | N.A | N.A |
| Zaks Tal Zvi | Chief Medical Officer | 08-09-2020 | -4,960 | 57.88 | 287,085.00 |
| Bancel Stephane | Chief Executive Officer | 04-09-2020 | -700 | 59.48 | 41,636.00 |
| Bancel Stephane | Chief Executive Officer | 03-09-2020 | -10,000 | 65.65 | 656,500.00 |
| Hoge Stephen | President | 03-09-2020 | +10,000 | 0.99 | +9,900.00 |
| Bancel Stephane | Chief Executive Officer | 02-09-2020 | -1,000 | N.A | N.A |
| Hoge Stephen | President | 02-09-2020 | +10,000 | N.A | N.A |
| Bancel Stephane | Chief Executive Officer | 01-09-2020 | -9,247 | 63.54 | 587,554.00 |
| Zaks Tal Zvi | Chief Medical Officer | 31-08-2020 | -4,807 | 64.81 | 311,542.00 |
| Bancel Stephane | Chief Executive Officer | 28-08-2020 | -5,969 | 66.19 | 395,088.00 |
| Bancel Stephane | Chief Executive Officer | 27-08-2020 | -10,000 | 69.91 | 699,100.00 |
| Bancel Stephane | Chief Executive Officer | 26-08-2020 | -1,000 | N.A | N.A |
| Zaks Tal Zvi | Chief Medical Officer | 24-08-2020 | -8,690 | 65.35 | 567,892.00 |
| Hoge Stephen | President | 24-08-2020 | -800 | 67.29 | 53,832.00 |
| Bancel Stephane | Chief Executive Officer | 21-08-2020 | -802 | 67.83 | 54,399.70 |
| Bancel Stephane | Chief Executive Officer | 20-08-2020 | -10,000 | 67.80 | 678,000.00 |
| Bancel Stephane | Chief Executive Officer | 19-08-2020 | -1,000 | N.A | N.A |
| AFEYAN NOUBAR | 17-08-2020 | -7,550,810 | N.A | N.A | |
| Zaks Tal Zvi | Chief Medical Officer | 17-08-2020 | +10,000 | N.A | N.A |
| Bancel Stephane | Chief Executive Officer | 17-08-2020 | -50,010 | N.A | N.A |
| Bancel Stephane | Chief Executive Officer | 14-08-2020 | -400 | 70.03 | 28,012.00 |
| Bancel Stephane | Chief Executive Officer | 13-08-2020 | -10,000 | 69.05 | 690,500.00 |
| Hoge Stephen | President | 13-08-2020 | +10,000 | N.A | N.A |
| Bancel Stephane | Chief Executive Officer | 13-08-2020 | -10,000 | 69.05 | 690,500.00 |
| Hoge Stephen | President | 12-08-2020 | -230 | 72.01 | 16,562.30 |
| Bancel Stephane | Chief Executive Officer | 12-08-2020 | -9,000 | 75.74 | 681,660.00 |
| Bancel Stephane | Chief Executive Officer | 12-08-2020 | -9,000 | 75.74 | 681,660.00 |
| Bancel Stephane | Chief Executive Officer | 10-08-2020 | -8,097 | 74.27 | 601,364.00 |
| Zaks Tal Zvi | Chief Medical Officer | 10-08-2020 | +10,000 | 20.93 | +209,300.00 |
| Bancel Stephane | Chief Executive Officer | 07-08-2020 | -5,363 | 73.84 | 396,004.00 |
| Bancel Stephane | Chief Executive Officer | 06-08-2020 | -10,000 | 75.82 | 758,200.00 |
| Bancel Stephane | Chief Executive Officer | 05-08-2020 | -9,000 | 77.49 | 697,410.00 |
| Hoge Stephen | President | 03-08-2020 | +10,000 | N.A | N.A |
| Zaks Tal Zvi | Chief Medical Officer | 03-08-2020 | +10,000 | 19.15 | +191,500.00 |
| Bancel Stephane | Chief Executive Officer | 03-08-2020 | -8,097 | 74.89 | 606,384.00 |
| Bancel Stephane | Chief Executive Officer | 31-07-2020 | -6,649 | 74.41 | 494,752.00 |
| Bancel Stephane | Chief Executive Officer | 30-07-2020 | -10,000 | 77.98 | 779,800.00 |
| Bancel Stephane | Chief Executive Officer | 29-07-2020 | -1,000 | N.A | N.A |
| Zaks Tal Zvi | Chief Medical Officer | 27-07-2020 | +10,000 | N.A | N.A |
| Hoge Stephen | President | 24-07-2020 | -1,107 | 73.33 | 81,176.30 |
| Bancel Stephane | Chief Executive Officer | 24-07-2020 | -3,852 | 73.14 | 281,735.00 |
| Hoge Stephen | President | 24-07-2020 | -1,638 | 72.56 | 118,853.00 |
| Bancel Stephane | Chief Executive Officer | 23-07-2020 | -10,000 | 82.22 | 822,200.00 |
| Hoge Stephen | President | 23-07-2020 | -325 | 78.52 | 25,519.00 |
| Hoge Stephen | President | 23-07-2020 | +10,000 | N.A | N.A |
| Bancel Stephane | Chief Executive Officer | 22-07-2020 | -1,000 | N.A | N.A |
| Bancel Stephane | Chief Executive Officer | 20-07-2020 | -1,004 | 82.19 | 82,518.80 |
| Zaks Tal Zvi | Chief Medical Officer | 20-07-2020 | -1,000 | 86.37 | 86,370.00 |
| Bancel Stephane | Chief Executive Officer | 17-07-2020 | -645 | 90.99 | 58,688.60 |
| Bancel Stephane | Chief Executive Officer | 16-07-2020 | -10,000 | 80.39 | 803,900.00 |
| Bancel Stephane | Chief Executive Officer | 15-07-2020 | -9,000 | 87.84 | 790,560.00 |
| NABEL ELIZABETH G | 15-07-2020 | +10,948 | N.A | N.A | |
| Hoge Stephen | President | 13-07-2020 | +10,000 | 0.99 | +9,900.00 |
| Zaks Tal Zvi | Chief Medical Officer | 13-07-2020 | +10,000 | 19.15 | +191,500.00 |
| Bancel Stephane | Chief Executive Officer | 10-07-2020 | -497 | 64.70 | 32,155.90 |
| Bancel Stephane | Chief Executive Officer | 09-07-2020 | -10,000 | 62.04 | 620,400.00 |
| Zaks Tal Zvi | Chief Medical Officer | 08-07-2020 | +10,000 | 20.93 | +209,300.00 |
| Bancel Stephane | Chief Executive Officer | 08-07-2020 | -1,000 | N.A | N.A |
| Zaks Tal Zvi | Chief Medical Officer | 07-07-2020 | +24,121 | 19.15 | +461,917.00 |
| Bancel Stephane | Chief Executive Officer | 06-07-2020 | -1,000 | 57.85 | 57,850.00 |
| Hoge Stephen | President | 06-07-2020 | +10,000 | N.A | N.A |
| Bancel Stephane | Chief Executive Officer | 02-07-2020 | -10,000 | 59.94 | 599,400.00 |
| Hoge Stephen | President | 02-07-2020 | +10,000 | N.A | N.A |
| Bancel Stephane | Chief Executive Officer | 01-07-2020 | -9,344 | 62.92 | 587,924.00 |
| Bancel Stephane | Chief Executive Officer | 01-07-2020 | -1,000 | N.A | N.A |
| Tallett Elizabeth E | 01-07-2020 | +11,229 | 61.59 | +691,594.00 | |
| Zaks Tal Zvi | Chief Medical Officer | 30-06-2020 | -12,967 | 63.56 | 824,182.00 |
| Bancel Stephane | Chief Executive Officer | 26-06-2020 | -932 | 61.69 | 57,495.10 |
| Bancel Stephane | Chief Executive Officer | 25-06-2020 | -10,000 | 67.00 | 670,000.00 |
| Hoge Stephen | President | 24-06-2020 | -2,595 | 65.11 | 168,960.00 |
| Bancel Stephane | Chief Executive Officer | 24-06-2020 | -1,000 | N.A | N.A |
| Hoge Stephen | President | 23-06-2020 | -100 | 64.95 | 6,495.00 |
| Bancel Stephane | Chief Executive Officer | 22-06-2020 | -4,521 | 65.92 | 298,024.00 |
| Bancel Stephane | Chief Executive Officer | 19-06-2020 | -500 | 65.52 | 32,760.00 |
| HENDERSON LORI M. | General Counsel and Secretary | 18-06-2020 | +64,000 | N.A | N.A |
| Zaks Tal Zvi | Chief Medical Officer | 16-06-2020 | +15,631 | 19.15 | +299,334.00 |
| Hoge Stephen | President | 15-06-2020 | -910 | 66.42 | 60,442.20 |
| Bancel Stephane | Chief Executive Officer | 12-06-2020 | -5,000 | 61.13 | 305,650.00 |
| Hoge Stephen | President | 12-06-2020 | -2,093 | 61.10 | 127,882.00 |
| Bancel Stephane | Chief Executive Officer | 10-06-2020 | -3,435 | 58.80 | 201,978.00 |
| Bancel Stephane | Chief Executive Officer | 05-06-2020 | -4,809 | 57.42 | 276,133.00 |
| Bancel Stephane | Chief Executive Officer | 01-06-2020 | -4,878 | 62.67 | 305,704.00 |
| Bancel Stephane | Chief Executive Officer | 01-06-2020 | -4,878 | 62.67 | 305,704.00 |
| Bancel Stephane | Chief Executive Officer | 29-05-2020 | -463 | 61.01 | 28,247.60 |
| Bancel Stephane | Chief Executive Officer | 29-05-2020 | -7,820 | 58.03 | 453,795.00 |
| Zaks Tal Zvi | Chief Medical Officer | 26-05-2020 | +42,570 | N.A | N.A |
| Hoge Stephen | President | 26-05-2020 | -200 | 66.11 | 13,222.00 |
| Hoge Stephen | President | 26-05-2020 | -1,910 | 62.54 | 119,451.00 |
| Bancel Stephane | Chief Executive Officer | 22-05-2020 | -1,238 | 67.76 | 83,886.90 |
| HENDERSON LORI M. | General Counsel and Secretary | 20-05-2020 | +64,000 | N.A | N.A |
| Bancel Stephane | Chief Executive Officer | 20-05-2020 | -8,372 | 70.00 | 586,040.00 |
| HENDERSON LORI M. | General Counsel and Secretary | 20-05-2020 | -64,000 | 70.00 | 4,480,000.00 |
| Bancel Stephane | Chief Executive Officer | 20-05-2020 | -4,186 | 70.00 | 293,020.00 |
| Zaks Tal Zvi | Chief Medical Officer | 19-05-2020 | +12,563 | 12.21 | +153,394.00 |
| Zaks Tal Zvi | Chief Medical Officer | 19-05-2020 | -125,044 | 78.16 | 9,773,440.00 |
| Kim Lorence H. | Chief Financial Officer | 15-05-2020 | -2,600 | 63.80 | 165,880.00 |
| Bancel Stephane | Chief Executive Officer | 15-05-2020 | -1,577 | N.A | N.A |
| Hoge Stephen | President | 13-05-2020 | -200 | 60.77 | 12,154.00 |
| Andres Juan | See remarks | 13-05-2020 | -1,300 | 66.89 | 86,957.00 |
| Andres Juan | See remarks | 13-05-2020 | -38,089 | 64.44 | 2,454,460.00 |
| Bancel Stephane | Chief Executive Officer | 12-05-2020 | -55,568 | N.A | N.A |
| Hoge Stephen | President | 12-05-2020 | -100 | 66.69 | 6,669.00 |
| Bancel Stephane | Chief Executive Officer | 11-05-2020 | -3,376 | 59.57 | 201,108.00 |
| Flagship Ventures Fund IV, L.P. | 11-05-2020 | -8,390,000 | N.A | N.A | |
| Bancel Stephane | Chief Executive Officer | 08-05-2020 | -2,109 | 59.20 | 124,853.00 |
| Andres Juan | See remarks | 01-05-2020 | -3,934 | 49.69 | 195,480.00 |
| Horning Sandra | 29-04-2020 | +17,195 | N.A | N.A | |
| LANGER ROBERT | 29-04-2020 | +18,270 | N.A | N.A | |
| Slaoui Moncef | 29-04-2020 | +18,270 | N.A | N.A | |
| Berenson Stephen | 29-04-2020 | +18,270 | N.A | N.A | |
| SAGAN PAUL | 29-04-2020 | +18,270 | N.A | N.A | |
| AFEYAN NOUBAR | 29-04-2020 | +18,270 | N.A | N.A | |
| Andres Juan | See remarks | 15-04-2020 | -9,944 | 37.78 | 375,684.00 |
| Bancel Stephane | Chief Executive Officer | 15-04-2020 | -2,936 | N.A | N.A |
| 15-04-2020 | -400 | 38.24 | 15,296.00 | ||
| Hoge Stephen | President | 13-04-2020 | -1,049 | 32.90 | 34,512.10 |
| Bancel Stephane | Chief Executive Officer | 13-04-2020 | -3,139 | 32.00 | 100,448.00 |
| Zaks Tal Zvi | Chief Medical Officer | 13-04-2020 | -10,000 | 32.00 | 320,000.00 |
| Andres Juan | See remarks | 03-04-2020 | +13,697 | N.A | N.A |
| Zaks Tal Zvi | Chief Medical Officer | 03-04-2020 | -10,000 | 32.81 | 328,100.00 |
| Hoge Stephen | President | 13-03-2020 | -1,110 | 22.43 | 24,897.30 |
| SAGAN PAUL | 14-02-2020 | +52,631 | 19.00 | +999,989.00 | |
| Stéphane Bancel | Chief Executive Officer; Director | 27-12-2019 | -11,046 | 19.53 | 215,728.38 |
| Stéphane Bancel | Chief Executive Officer; Director | 20-12-2019 | -11,046 | 19.69 | 217,495.74 |
| Stéphane Bancel | Chief Executive Officer; Director | 13-12-2019 | -11,046 | 18.53 | 204,682.38 |
| Tal Zaks | Chief Medical Officer | 12-12-2019 | -100,000 | 18.54 | 1,854,000.00 |
| Director | 11-12-2019 | -199,935 | 18.65 | 3,728,787.75 | |
| Director | 11-12-2019 | -38,366 | 18.65 | 715,525.90 | |
| Francois Nader | Director | 10-12-2019 | +17,889 | N.A | N.A |
| Director | 10-12-2019 | -4,092 | 18.96 | 77,584.32 | |
| Director | 10-12-2019 | -21,325 | 18.96 | 404,322.00 | |
| Ed M. Kania | 10-12-2019 | -100,000 | 18.81 | 1,881,000.00 | |
| Francois Nader | Director | 10-12-2019 | +39,720 | N.A | N.A |
| Director | 09-12-2019 | -144,423 | 18.99 | 2,742,592.77 | |
| Director | 09-12-2019 | -27,714 | 18.99 | 526,288.86 | |
| Stéphane Bancel | Chief Executive Officer; Director | 09-12-2019 | +42,132 | N.A | N.A |
| Director | 09-12-2019 | -6,292,342 | N.A | N.A | |
| Director | 09-12-2019 | -1,207,658 | N.A | N.A | |
| Director | 09-12-2019 | -1,735,720 | N.A | N.A | |
| Chief Financial Officer | 06-12-2019 | +229,358 | 20.64 | +4,733,949.12 | |
| Stéphane Bancel | Chief Executive Officer; Director | 06-12-2019 | -4,646 | 19.42 | 90,225.32 |
| Stéphane Bancel | Chief Executive Officer; Director | 06-12-2019 | -6,200 | 20.43 | 126,666.00 |
| Stéphane Bancel | Chief Executive Officer; Director | 06-12-2019 | -200 | 20.95 | 4,190.00 |
| Chief Financial Officer | 06-12-2019 | +229,357 | 20.64 | +4,733,928.48 | |
| Chief Financial Officer | 06-12-2019 | -147,528 | 20.39 | 3,008,095.92 | |
| Chief Financial Officer | 06-12-2019 | -89,698 | 19.34 | 1,734,759.32 | |
| Chief Financial Officer | 06-12-2019 | -229,358 | N.A | N.A | |
| Chief Financial Officer | 06-12-2019 | -229,357 | N.A | N.A | |
| Chief Financial Officer | 06-12-2019 | -1,306 | 20.93 | 27,334.58 | |
| Stéphane Bancel | Chief Executive Officer; Director | 29-11-2019 | -11,046 | 20.54 | 226,884.84 |
| Stéphane Bancel | Chief Executive Officer; Director | 22-11-2019 | -11,046 | 20.48 | 226,222.08 |
| Peter Barton Hutt | Director | 20-11-2019 | -200,000 | N.A | N.A |
| Peter Barton Hutt | Director | 20-11-2019 | -200,000 | 20.18 | 4,036,000.00 |
| Peter Barton Hutt | Director | 20-11-2019 | +200,000 | 0.04 | +8,000.00 |
| Stéphane Bancel | Chief Executive Officer; Director | 15-11-2019 | -336 | 19.38 | 6,511.68 |
| Stéphane Bancel | Chief Executive Officer; Director | 15-11-2019 | -10,710 | 19.02 | 203,704.20 |
| Stéphane Bancel | Chief Executive Officer; Director | 08-11-2019 | -11,046 | 17.38 | 191,979.48 |
| Stéphane Bancel | Chief Executive Officer; Director | 01-11-2019 | -4,500 | 16.68 | 75,060.00 |
| Stéphane Bancel | Chief Executive Officer; Director | 01-11-2019 | -4,500 | 16.68 | 75,060.00 |
| Stéphane Bancel | Chief Executive Officer; Director | 01-11-2019 | -6,546 | 15.66 | 102,510.36 |
| Stéphane Bancel | Chief Executive Officer; Director | 01-11-2019 | -6,546 | 15.66 | 102,510.36 |
| Chief Financial Officer | 23-09-2019 | -5,000 | N.A | N.A | |
| Peter Barton Hutt | Director | 17-09-2019 | +100,000 | 0.04 | +4,000.00 |
| Peter Barton Hutt | Director | 17-09-2019 | -100,000 | 17.63 | 1,763,000.00 |
| Peter Barton Hutt | Director | 17-09-2019 | -100,000 | N.A | N.A |
| Elizabeth G. Nabel | Director | 27-06-2019 | +54,660 | N.A | N.A |
| Paul L. Sagan | Director | 27-06-2019 | +54,660 | N.A | N.A |
| Moncef Slaoui | Director | 27-06-2019 | +54,660 | N.A | N.A |
| Robert S. Langer | Director | 27-06-2019 | +54,660 | N.A | N.A |
| Noubar B. Afeyan | Director | 27-06-2019 | +54,660 | N.A | N.A |
| Israel Ruiz | Director | 27-06-2019 | +54,660 | N.A | N.A |
| Peter Barton Hutt | Director | 27-06-2019 | +54,660 | N.A | N.A |
| Stephen A. Berenson | Director | 27-06-2019 | +54,660 | N.A | N.A |